HCPCS Level II J7329: Hyaluronan (Trivisc) intra-articular injection, 1 mg
HCPCS Level II code J7329 describes hyaluronan or derivative, Trivisc, for intra-articular injection, 1 mg, representing a single-dose injectable viscosupplement used to treat joint conditions via intra-articular administration; service type is intra-articular viscosupplement injection and the typical site of service is the clinic, physician office, or ambulatory surgical center where joint injections are performed.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J7329 policy alerts
Get alerted when payer policies referencing J7329 are released or updated.
Monitor payer policy activity